Search Tag: finerenone
2024 01 Sep
A pooled analysis of three major trials presented at #ESCCongress2024 did not show significant reductions in cardiovascular death with finerenone. However, significant decreases in all-cause mortality, cardiovascular events, and kidney outcomes were observed. Cardiovascular diseases, chronic kidney disease (CKD), and metabolic conditions...Read more